Literature DB >> 15297997

Shaping the intimate: influences on the experience of everyday nerves.

David Healy1.   

Abstract

Before 1980, most people experiencing common nervous problems and who sought medical help complained of anxiety and were treated for anxiety. Similar experiences increasingly led to complaints of or treatment for panic attacks in the late 1980s and early 1990s, and to complaints of or treatment for mood disorders by the mid-1990s. Today, such patients seem once again increasingly likely to complain of and be treated for anxiety. This paper reviews a series of mechanisms whereby company marketing can both transform the perceptions of physicians and shape the experiences of those seeking treatment and the self-understanding of those not in treatment. These include the standard ploys of company sales departments to increase demand for products, including celebrity endorsements, the sponsoring of educational events and a host of reminders. The portfolio of marketing manoeuvres has grown, though, by translating educational events and celebrity events into the arena of scientific research: clinical trials have increasing become part of the marketing of disorders and their treatments; ghost-written scientific papers are authored by celebrity researchers. The portfolio of marketing manoeuvres has also grown to encompass new ways of creating fashion through medical activism, by setting up patient groups and disease awareness campaigns. The result is a transformation and growth in disorders tailor-made to fit ever more visible drugs.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15297997     DOI: 10.1177/0306312704042620

Source DB:  PubMed          Journal:  Soc Stud Sci        ISSN: 0306-3127            Impact factor:   3.885


  16 in total

1.  The texture of the real: experimentation and experience in schizophrenia.

Authors:  Elizabeth Bromley
Journal:  Cult Med Psychiatry       Date:  2012-03

2.  Manufacturing consensus.

Authors:  David Healy
Journal:  Cult Med Psychiatry       Date:  2006-06

3.  For my wellness, not just my illness: North Americans' use of dietary supplements.

Authors:  Mark Nichter; Jennifer Jo Thompson
Journal:  Cult Med Psychiatry       Date:  2006-06

4.  Getting to yes: corporate power and the creation of a psychopharmaceutical blockbuster.

Authors:  Kalman Applbaum
Journal:  Cult Med Psychiatry       Date:  2009-06

5.  Teaching critical thinking in psychiatric training: a role for the social sciences.

Authors:  Elizabeth Bromley; Joel T Braslow
Journal:  Am J Psychiatry       Date:  2008-11       Impact factor: 18.112

6.  The inverse benefit law: how drug marketing undermines patient safety and public health.

Authors:  Howard Brody; Donald W Light
Journal:  Am J Public Health       Date:  2011-01-13       Impact factor: 9.308

Review 7.  How an age of anxiety became an age of depression.

Authors:  Allan V Horwitz
Journal:  Milbank Q       Date:  2010-03       Impact factor: 4.911

8.  Antidepressant utilization in primary care in a Spanish region: impact of generic and reference-based pricing policy (2000-2004).

Authors:  Amalia Ubeda; Encarna Cardo; Noelia Sellés; Rocio Broseta; José Luis Trillo; Fernando Fernández-Llimós
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2007-01-17       Impact factor: 4.328

9.  Morals, medicine and change: morality brokers, social phobias, and French psychiatry.

Authors:  Stephanie Lloyd
Journal:  Cult Med Psychiatry       Date:  2008-06

10.  Mortality in schizophrenia and related psychoses: data from two cohorts, 1875-1924 and 1994-2010.

Authors:  David Healy; Joanna Le Noury; Margaret Harris; Mohammed Butt; Stefanie Linden; Chris Whitaker; Lu Zou; Anthony P Roberts
Journal:  BMJ Open       Date:  2012-10-08       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.